Great expectations: patients’ preferences for clinically significant results from genomic sequencing
Authors:
- 21 March 2023
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 142 (4) , 553-562
Abstract
We aimed to describe patient preferences for a broad range of secondary findings (SF) from genomic sequencing (GS) and factors driving preferences. We assessed preference data within a trial of the Genomics ADvISER, (SF decision aid) among adult cancer patients. Participants could choose from five categories of SF: (1) medically actionable; (2) polygenic risks; (3) rare diseases; (4) early-onset neurological diseases; and (5) carrier status. We analyzed preferences using descriptive statistics and drivers of preferences using multivariable logistic regression models. The 133 participants were predominantly European (74%) or East Asian or mixed ancestry (13%), female (90%), and aged > 50 years old (60%). The majority chose to receive SF. 97% (129/133) chose actionable findings with 36% (48/133) choosing all 5 categories. Despite the lack of medical actionability, participants were interested in receiving SF of polygenic risks (74%), carrier status (75%), rare diseases (59%), and early-onset neurologic diseases (53%). Older participants were more likely to be interested in receiving results for early-onset neurological diseases, while those exhibiting lower decisional conflict were more likely to select all categories. Our results highlight a disconnect between cancer patient preferences and professional guidelines on SF, such as ACMG’s recommendations to only return medically actionable secondary findings. In addition to clinical evidence, future guidelines should incorporate patient preferences.Keywords
Funding Information
- Canadian Institutes of Health Research (136664, 425969)
This publication has 35 references indexed in Scilit:
- Preferences for results delivery from exome sequencing/genome sequencingGenetics in Medicine, 2014
- Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencingGenetics in Medicine, 2014
- Parents' Preferences for Return of Results in Pediatric Genomic ResearchPublic Health Genomics, 2014
- Return of incidental findings in genomic medicine: measuring what patients value—development of an instrument to measure preferences for information from next-generation testing (IMPRINT)Genetics in Medicine, 2013
- Whole-genome sequencing in health careEuropean Journal of Human Genetics, 2013
- Effects of informed consent for individual genome sequencing on relevant knowledgeClinical Genetics, 2012
- Rethinking the Objectives of Decision Aids: A Call for Conceptual ClarityMedical Decision Making, 2007
- International Patient Decision Aid Standards (IPDAS): beyond decision aids to usual design of patient education materialsHealth Expectations, 2007
- Attitudes and Knowledge about Presymptomatic Genetic Testing among Individuals at High Risk for Familial, Early-Onset Alzheimer's DiseaseGenetic Testing, 2003
- Validation of a Decisional Conflict ScaleMedical Decision Making, 1995